SPOTLIGHT: AARP study shows drug prices outpaced inflation

Wholesale prices for brand-name prescription drugs used by older Americans rose at more than twice the rate of inflation during the year that ended March 31, the AARP says. The 6.6 percent increase was down slightly from previous price hikes but still well ahead of the general inflation rate. The biggest increases were in drugs for diabetes, high blood pressure, and other heart-disease treatments. Story

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.